Trinity Biotech (TRIB) Misses Q4 EPS by 21c

Trinity Biotech (NASDAQ: TRIB) reported Q4 EPS of ($0.27), $0.21 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $18 million versus the consensus estimate of $18 million.

For earnings history and earnings-related data on Trinity Biotech (TRIB) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M